Published on 18 Apr 2024 on Zacks via Yahoo Finance
Elevance Health, Inc. ELV reported first-quarter 2024 adjusted earnings of $10.64 per share, which surpassed the Zacks Consensus Estimate by 0.9%. The bottom line climbed 12.5% year over year.
Operating revenues rose 0.9% year over year to almost $42.3 billion in the quarter under review. However, the top line missed the consensus mark by 0.4%.